OZALIN

LIVE

Serial Number

79422037

Owner

Primex Pharmaceuticals AG

Attorney

Elizabeth A. Cominolli

Filing Date

Mar 21, 2025

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OZALIN Trademark

Serial Number: 79422037 • Registration: 8200321

OZALIN is a trademark filed by Primex Pharmaceuticals AG on March 21, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Primex Pharmaceuticals AG (4 trademarks)

Reiffergässli 3

Entity Type: 84

Legal Representation

Attorney of Record

Elizabeth A. Cominolli

1,255 trademarks filed View all →

Correspondence Address

Elizabeth A. Cominolli Markert & Cominolli PLLC

100 S. Clinton Ave., 24th Floor

Rochester, NY 14604

United States

Trademark Details

Filing Date

March 21, 2025

Registration Date

April 7, 2026

Published for Opposition

February 17, 2026

Goods & Services

Pharmaceutical preparations for premedication and sedation, namely sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use; anaesthetics; sedatives

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 7, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Apr 7, 2026 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 17, 2026 NPUB

PUBLISHED FOR OPPOSITION

Feb 17, 2026 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 11, 2026 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 22, 2026 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 19, 2026 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 19, 2026 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 19, 2026 TROA

REFUSAL PROCESSED BY IB

Oct 31, 2025 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 8, 2025 RFCS

REFUSAL PROCESSED BY MPU

Oct 8, 2025 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 26, 2025 RFCR

NON-FINAL ACTION WRITTEN

Aug 25, 2025 CNRT

ASSIGNED TO EXAMINER

Aug 20, 2025 DOCK

APPLICATION FILING RECEIPT MAILED

May 5, 2025 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 5, 2025 NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

May 5, 2025 LIMI

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Apr 17, 2025 SDRC

Related Trademarks

More from this Owner

OZASED

OZALIN

More in Same Class

BWH-85

ARCANA ESTABLISHED ENLIGHTENED ELITE

EVIDENCEBIOTICS

AMBIVAX

ESCAALATE

VICHY INTEGRATIVE MEDICAL HEALTH